Study guide
13.1 Pediatric "One-Pill-Can-Kill" Agents and Pediatric Toxic Dose Thresholds
Certified Specialist in Poison Information CSPI
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacology & Toxicology Principles
1.1 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination Alterations in Overdose 1.2 Toxicodynamics, Receptor Pharmacology, and Dose-Response Relationships 1.3 Cellular and Biochemical Mechanisms of Toxicity 1.4 Hepatic Biotransformation, Phase I/II Reactions, and CYP450 Interactions
2 Chapter 2: Poison Center Case Assessment Fundamentals
2.1 Exposure History: The Questions That Change Management 2.2 Toxicologic Calculations: Doses, Concentrations, and Conversions
3 Chapter 3: Analgesics, Opioids & Over-the-Counter Medications
3.1 Acetaminophen Overdose: Pathophysiology, Rumack-Matthew Nomogram, and NAC Protocols 3.2 Salicylates: Pathophysiology, Acid-Base Derangements, and Urinary Alkalinization 3.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Miscellaneous OTC Analgesics 3.4 Opioids, Opioid Toxidrome, and Naloxone Titration 3.5 Cough and Cold Products, Antihistamines, Muscle Relaxants, and Local Anesthetics
4 Chapter 4: Psychotropic & Neurologic Medications
4.1 Tricyclic and Cyclic Antidepressants: Cardiotoxicity, ECG Findings, and Bicarbonate Therapy 4.2 SSRIs, SNRIs, Novel Antidepressants, and Serotonin Syndrome 4.3 Antipsychotics, Neuroleptic Malignant Syndrome, and Lithium Neurotoxicity 4.4 Benzodiazepines, Z-drugs, Barbiturates, and Major Anticonvulsants
5 Chapter 5: Cardiovascular Drugs & Substances of Abuse
5.1 Beta-Blockers, Calcium Channel Blockers, and High-Dose Insulin Euglycemia Therapy 5.2 Digoxin and Cardiac Glycosides: Mechanism, Arrhythmias, and Digoxin Immune Fab 5.3 Sympathomimetics, Cocaine, Amphetamines, Synthetic Cannabinoids, and Hallucinogens 5.4 Caffeine, Theophylline, and Over-the-Counter Stimulants 5.5 Cannabis, GHB, Nitrites, and Nicotine Products
6 Chapter 6: Endocrine, Antimicrobial & Miscellaneous Medications
6.1 Antidiabetic Agents, Metformin Lactic Acidosis, and Thyroid Hormone 6.2 Antimicrobials, Vitamins and Minerals, and Veterinary Products
7 Chapter 7: Household, Chemical & Inhalational Toxins
7.1 Caustic and Corrosive Ingestions: Acids vs. Alkalis, Tissue Necrosis, and Endoscopic Grading 7.2 Cleaning Products, Personal Care Products, and Household Chemicals 7.3 Hydrocarbons and Halogenated Solvents: Aspiration Risks and Myocardial Sensitization 7.4 Carbon Monoxide, Cyanide, Hydrogen Sulfide, and Inhalational Irritants
8 Chapter 8: Pesticides, Heavy Metals & Toxic Alcohols
8.1 Organophosphates, Carbamates, Pyrethroids, and Cholinesterase Antidotes 8.2 Rodenticides, Herbicides, Repellents, and Other Pesticides 8.3 Ethylene Glycol, Methanol, and Isopropanol: Metabolism, Osmolal Gaps, and Fomepizole 8.4 Lead, Mercury, Arsenic, Iron Toxicity, and Chelation Protocols
9 Chapter 9: Toxic Plants, Mushrooms & Foodborne Toxins
9.1 Toxic Plants: Cardiac Glycosides, Anticholinergics, Nicotinics, and Sodium Channel Activators 9.2 Oxalate, Irritant, Hallucinogenic, and Stimulant Plants 9.3 Mushroom Poisoning: Amatoxins, Monomethylhydrazine, Muscarine, and Coprine 9.4 Scombroid, Ciguatera, Tetrodotoxin, Paralytic Shellfish, and Botulism 9.5 Bacterial Foodborne Illness and Food Poisoning Triage
10 Chapter 10: Envenomations & Bites
10.1 North American Pit Vipers (Crotalinae): Envenomation Assessment and Antivenom Management 10.2 Elapid Snakebites (Coral Snakes): Neurotoxicity, Clinical Course, and Antivenin 10.3 Black Widow, Brown Recluse Spiders, and Bark Scorpion Stings 10.4 Hymenoptera Stings, Ticks, and Other Arthropods 10.5 Marine Envenomations: Jellyfish, Stingrays, Catfish, and Lionfish
11 Chapter 11: Clinical Assessment, Toxidromes & Triage
11.1 Recognition of Classic Toxidromes and Vital Sign Pattern Analysis 11.2 Severity Assessment, Exposure Urgency, and Poison Center Telephone Triage Flow 11.3 Home Observation vs. Emergency Department Referral Decision-Making 11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing
12 Chapter 12: Decontamination, Antidotes & Elimination
12.1 Gastrointestinal Decontamination: Activated Charcoal, Whole Bowel Irrigation, and Contraindications 12.2 Essential Poison Center Antidotes: Indications, Mechanisms, and Titration Pearls 12.3 Enhanced Elimination: Urinary Alkalinization, MDAC, Hemodialysis, and Hemoperfusion 12.4 Resuscitation and Supportive Care: Seizures, Hyperthermia, and Hemodynamic Shock
13 Chapter 13: Pediatric Poisoning & High-Risk Hazards
13.1 Pediatric "One-Pill-Can-Kill" Agents and Pediatric Toxic Dose Thresholds 13.2 Button Batteries, Rare-Earth Magnets, and Expandable Foreign Bodies 13.3 Developmental Ingestion Patterns, Liquid Detergent Pods, and Essential Oils
14 Chapter 14: Communication, NPDS Documentation & Prevention
14.1 Emergency Call Communication, Panicked Callers, and Healthcare Provider Consultations 14.2 National Poison Data System (NPDS) Coding Standards and Medical Outcome Categorization 14.3 Scheduled Follow-up Protocols, Medical Toxicologist Consultation Triggers, and Public Health Surveillance 14.4 Evidence-Based Poison Prevention, PPPA Regulations, and Community Outreach
13.1 Pediatric "One-Pill-Can-Kill" Agents and Pediatric Toxic Dose Thresholds
Key Takeaways Explain This Topic AI
The 'one-pill-can-kill' paradigm highlights pharmaceuticals where ingestion of a single adult dose by a toddler (10–15 kg) can produce life-threatening toxicity or fatality.
Sulfonylureas induce delayed, protracted, and refractory hypoglycemia that rebounds after intravenous dextrose, requiring octreotide as the definitive inhibitor of beta-cell insulin secretion.
Calcium channel blockers produce profound vasodilation, nodal conduction blocks, and characteristic hyperglycemia, requiring high-dose insulin euglycemia therapy, while central alpha-2 agonists mimic opioid toxidromes with bradypnea and periodic apnea.
Highly concentrated liquid formulations like oil of wintergreen (methyl salicylate) and camphor carry extreme single-sip lethal potential, precipitating rapid metabolic collapse or unheralded seizures.
Established pediatric weight-based thresholds (acetaminophen >150–200 mg/kg, ibuprofen >100 mg/kg, elemental iron >20 mg/kg, diphenhydramine >7.5 mg/kg) dictate triage urgency and hospital admission.
Last updated: September 2026
Pediatric toxicology possesses distinct pharmacological characteristics that diverge fundamentally from adult toxicology. The physiological immaturity of infants and young children—specifically a toddler weighing between 10 kg and 15 kg—creates extraordinary vulnerability to specific pharmaceutical classes. In a small child, tiny absolute amounts of potent adult medications represent massive, catastrophic weight-based overdoses. The "one-pill-can-kill" concept designates a high-risk group of xenobiotics in which the accidental ingestion of a single tablet, capsule, teaspoon, or patch by an exploratory toddler can precipitate fatal cardiovascular collapse, intractable neuroglycopenia, or central respiratory arrest.
Specialists in Poison Information (CSPIs) and acute care clinicians must maintain a zero-tolerance triage threshold for these agents: any confirmed or suspected exploratory ingestion of a "one-pill-can-kill" substance requires immediate emergency department transfer, prolonged observation, and preemptive antidotal readiness.
Physiological Vulnerabilities in Pediatric Poisoning
Several age-dependent physiological and pharmacokinetic factors amplify xenobiotic toxicity in toddlers: Toddler Physiological Profile (10–15 kg):
- Low Body Mass → 1 adult dose (e.g., 10 mg glipizide) = 1.0 mg/kg (massive overdose)
- Limited Glycogen Stores → Rapid exhaustion within 2–4 hours; neuroglycopenic coma
- High Basal Metabolism → Rapid oxygen consumption; accelerated metabolic crisis
- Immature Blood-Brain → Greater central penetration of lipophilic compounds
- Renal / Hepatic Flux → Immature glucuronidation shunts substrates to alternative pathways
Body Weight and Dose Magnification : A single adult dose of glipizide (10 mg) taken by a 70 kg adult represents 0.14 mg/kg. The same 10 mg tablet ingested by a 10 kg toddler represents 1.0 mg/kg—a seven-fold dose intensification capable of provoking profound, unyielding hyperinsulinemia.
Hepatic Glycogen Depletion : Toddlers possess minimal baseline hepatic glycogen stores and higher baseline glucose utilization rates. When sulfonylureas stimulate uninhibited insulin secretion, glycogen reserves are exhausted within hours, rapidly inducing irreversible hypoglycemic encephalopathy.
Myocardial and Vascular Dynamics : Pediatric cardiac output is heavily rate-dependent. Bradycardic toxins (calcium channel blockers, beta-blockers, clonidine) dramatically compromise systemic perfusion because the pediatric myocardium cannot substantially increase stroke volume to compensate for nodal deceleration.
The Cardinal "One-Pill-Can-Kill" Xenobiotics
Drug Class / Representative Agent Pediatric Lethal / Toxic Ingestion Core Pathophysiological Mechanism Clinical Manifestations & Latency Antidote & Poison Center Management
Sulfonylureas ; (Glipizide, Glyburide, Glimepiride) 1 tablet ; (e.g., 2.5–5 mg glyburide) Closes ATP-sensitive K⁺ channels on pancreatic β-cells, triggering continuous, autonomous insulin exocytosis. Delayed, profound hypoglycemia (can be delayed 8–18 hours); lethargy, seizures, permanent brain injury. Octreotide (1–1.25 mcg/kg SC/IV q6–12h); IV dextrose triggers rebound hyperinsulinemia; minimum 24-hour observation.
Calcium Channel Blockers ; (Verapamil, Diltiazem, Nifedipine) 1 tablet / capsule ; (especially ER/SR formulations) Inhibits L-type voltage-gated calcium channels in cardiac pacemaker, myocardium, and vascular smooth muscle; blocks pancreatic insulin release. Complete heart block, severe refractory hypotension, cardiogenic shock, and characteristic marked hyperglycemia . High-Dose Insulin Euglycemia (HIE) (1 unit/kg bolus + 1 unit/kg/h infusion with dextrose); IV calcium chloride; vasopressors; 24h observation.
Beta-Adrenergic Antagonists ; (Propranolol, Sotalol, Carvedilol) 1 tablet ; (e.g., 40–80 mg propranolol) Competitive blockade of β₁/β₂ receptors; lipid-soluble agents (propranolol) produce fast inward sodium channel blockade (INa). Bradycardia, severe hypotension, hypoglycemia, bronchospasm; propranolol triggers rapid seizures and QRS widening . High-Dose Glucagon (50 mcg/kg IV bolus over 1 min, then infusion); HIE; hypertonic sodium bicarbonate for wide QRS.
Central α₂-Agonists ; (Clonidine, Guanfacine, Tizanidine) 1 tablet or patch ; (e.g., 0.1 mg clonidine) Stimulates central presynaptic α₂-adrenergic receptors in the rostral ventrolateral medulla, abolishing peripheral sympathetic tone. Opioid toxidrome mimic : miosis, profound lethargy/coma, bradycardia, hypotension, and periodic central apnea . Supportive airway care; atropine for symptomatic bradycardia; Naloxone trial (0.1 mg/kg IV; ~20–30% clinical response); observation 12–24h.
Opioids ; (Methadone, Buprenorphine, Fentanyl) 1 tablet, film, or discarded patch Agonism at central μ-opioid receptors, depressing brainstem respiratory rhythm generation and medullary ventilatory response to hypercapnia. Coma, pinpoint miosis, severe bradypnea, respiratory arrest, hypothermia. Buprenorphine shows delayed, protracted apnea (2–6h onset) . Naloxone (0.1 mg/kg IV/IM/IN, max 2 mg; titrate to restore spontaneous ventilation); continuous infusion; observation 24h for methadone/buprenorphine.
Tricyclic Antidepressants ; (Amitriptyline, Imipramine, Desipramine) 1–2 tablets ; (e.g., 25–50 mg amitriptyline) Fast inward sodium channel blockade (INa), peripheral α₁ blockade, antimuscarinic blockade, and delayed rectifier K⁺ channel inhibition. Rapid deterioration within 1–2 hours: anticholinergic agitation followed by sudden status epilepticus, QRS > 100 ms, ventricular dysrhythmias, and shock . Hypertonic Sodium Bicarbonate (1–2 mEq/kg IV boluses targeting arterial pH 7.45–7.55 and QRS narrowing); avoid physostigmine.
Camphor ; (Vicks VapoRub, Spirits of Camphor) > 30–50 mg/kg ; (1 tsp concentrated spirit = 500 mg) Highly lipophilic terpene; rapid neuronal membrane incorporation, central GABA antagonism, and neuronal hyperexcitability. Sudden, unheralded generalized tonic-clonic seizures within 5–15 minutes ; rapid coma; pungent aromatic odor; vomiting. Benzodiazepines immediately for seizures; NO ipecac or gastric lavage (immediate aspiration risk during seizures); airway control.
Methyl Salicylate ; (Oil of Wintergreen) 1 teaspoon (5 mL) ; (= ~7,000 mg salicylate = >21 aspirin tabs) 98% pure methyl salicylate; uncouples mitochondrial oxidative phosphorylation, hyperstimulates medullary respiratory center, impairs Krebs cycle. Tachypnea, hyperpnea, vomiting, hyperpyrexia, tinnitus, severe mixed respiratory alkalosis and high anion gap metabolic acidosis. Urinary alkalinization with IV sodium bicarbonate; aggressive potassium repletion; emergent hemodialysis for severe acidemia or level >90–100 mg/dL.
Toxic Alcohols ; (Methanol, Ethylene Glycol) Single swallow (~5–10 mL) in a 10 kg toddler Metabolized via alcohol dehydrogenase (ADH) into highly toxic organic acids: formic acid (methanol) and glycolic/oxalic acids (ethylene glycol). High anion gap metabolic acidosis, elevated osmolar gap, altered mental status, visual impairment (methanol), acute tubular necrosis (ethylene glycol). Fomepizole (15 mg/kg IV loading dose); IV ethanol if fomepizole unavailable; sodium bicarbonate; emergent hemodialysis .
- Deep-Dive Pathophysiology of High-Risk Single-Dose Lethal Agents
- 1. Sulfonylureas: The Rebound Dextrose Trap and Octreotide
Sulfonylureas (glipizide, glyburide, glimepiride) bind to the SUR1 regulatory subunit of ATP-sensitive inward-rectifier potassium (KATP) channels on pancreatic β-islet cells. This binding causes channel closure, membrane depolarization, calcium influx via voltage-gated L-type channels, and continuous, autonomous insulin exocytosis independent of ambient serum glucose concentrations. Sulfonylurea Overdose Pathophysiology & The Dextrose Trap:
- Sulfonylurea Ingestion → Binds SUR1 → Closes K_ATP Channels → Membrane Depolarization
- ↓
- Severe Hypoglycemia ← Persistent Hyperinsulinemia ← Ca2+ Influx via L-Type Channels
- ↓
- Bolus IV Dextrose administered → Transient Euglycemia → Stimulates MORE Insulin Secretion
- ↓
- Devastating Rebound Hypoglycemia
Definitive Solution:
- OCTREOTIDE (Somatostatin Analogue) → Activates Somatostatin SSTR2/SSTR5 Receptors
- → Hyperpolarizes β-cell → Blocks Ca2+ Influx
- → ARRESTS Insulin Secretion
The Dextrose Trap : Administering repeated intravenous boluses of hypertonic dextrose (e.g., D10W or D25W) provides a temporary surge in blood glucose, which in turn acts as a powerful physiological stimulus for further insulin release from sulfonylurea-primed β-cells. Once the dextrose infusion slows or ends, the child crashes into devastating rebound hypoglycemia .
Octreotide Rescue : Octreotide is a synthetic somatostatin analogue that binds to somatostatin receptor subtypes 2 and 5 (SSTR₂, SSTR₅) on pancreatic β-cells. It activates G-protein-coupled inward-rectifying potassium channels and inhibits voltage-dependent calcium channels, hyperpolarizing the cell membrane and directly arresting insulin exocytosis.
Pediatric Dosing : Administer octreotide at 1.0 to 1.25 mcg/kg subcutaneously or intravenously every 6 to 12 hours (maximum single dose 50 mcg). Alternatively, a continuous infusion of 1 mcg/kg/hour can be titrated.
Mandatory Observation Window : Because sulfonylurea hypoglycemia is notoriously delayed (frequently occurring 8 to 18 hours post-ingestion as enteric absorption continues), every pediatric patient with suspected sulfonylurea ingestion must be admitted for a minimum 24-hour observation period with hourly bedside blood glucose checks.
2. Calcium Channel Blockers: The Hyperglycemic Shock Signature
Calcium channel blockers (CCBs), particularly phenylalkylamines (verapamil) and benzothiazepines (diltiazem), along with dihydropyridines (nifedipine, amlodipine), block L-type voltage-sensitive calcium channels. In a toddler, a single sustained-release tablet can produce refractory cardiogenic shock within 2 to 6 hours.
Cardiovascular Collapse : Inhibition of calcium entry into Phase 0 and Phase 2 of sinoatrial and atrioventricular nodal action potentials produces profound sinus bradycardia, high-degree AV block, and decreased myocardial contractility (negative inotropy). Peripheral vascular smooth muscle relaxation induces profound vasodilatory shock.
The Diagnostic Hallmark—Hyperglycemia : The exocytosis of insulin from pancreatic β-islet cells is strictly dependent on calcium influx through L-type channels. CCB toxicity shuts down endogenous insulin release while simultaneously inducing peripheral insulin resistance. Consequently, marked hyperglycemia (>200 to 400 mg/dL) in a child presenting with bradycardia and hypotension strongly points to CCB poisoning rather than beta-blocker poisoning (which typically produces hypoglycemia or euglycemia).
High-Dose Insulin Euglycemia Therapy (HIET) : During toxic shock, the stressed myocardium switches from its preferred substrate (free fatty acids) to carbohydrates (glucose). However, hypoinsulinemia prevents myocardial glucose uptake. High-dose regular insulin (1 unit/kg IV bolus followed by a continuous infusion of 1 to 10 units/kg/hour, accompanied by concentrated dextrose D10W/D25W to maintain euglycemia) restores myocardial carbohydrate metabolism, exerts powerful positive inotropic effects, and overcomes peripheral vascular collapse.
3. Central α₂-Adrenergic Agonists: The Opioid Toxidrome Mimic
Central α₂-adrenergic agonists (clonidine, guanfacine, tizanidine, and topical ocular formulations like brimonidine and apraclonidine) stimulate presynaptic α₂-receptors within the nucleus tractus solitarii and rostral ventrolateral medulla. This central agonism shuts off efferent peripheral sympathetic outflow, dramatically decreasing circulating epinephrine and norepinephrine.
Toxidrome Presentation : Toddlers present with a clinical syndrome that is virtually indistinguishable from an opioid toxidrome: marked somnolence or coma, pinpoint miosis, bradycardia, hypotension, hypothermia, and periodic central apnea .
Topical / Ocular Route Hazard : A single drop of 0.2% brimonidine ophthalmic solution swallowed by an infant or toddler contains roughly 0.1 mg of drug—equivalent to a full adult systemic dose—and rapidly triggers profound coma and respiratory arrest.
Naloxone Role : Naloxone competitively displaces endogenous β-endorphin, which is released downstream of central α₂ stimulation. While naloxone restores spontaneous ventilation in approximately 20% to 30% of pediatric clonidine exposures, response is variable and transient. Airway protection, bag-valve-mask ventilation, and fluid resuscitation remain the cornerstones of management.
4. Camphor and Methyl Salicylate: Lethal Liquids
Concentrated liquid preparations represent the most rapid and unpredictable pediatric poisoning hazards:
Camphor : Present in over-the-counter chest rubs (e.g., Vicks VapoRub, 4.8% camphor) and concentrated spirits of camphor (10–20% camphor). Toxic thresholds begin at >30–50 mg/kg , and a lethal dose is roughly 50–100 mg/kg (<1 teaspoon of spirits of camphor). Camphor is rapidly absorbed through gastrointestinal mucosa and across the blood-brain barrier. It induces sudden, unheralded generalized tonic-clonic seizures within 5 to 15 minutes of ingestion without preceding nausea or drowsiness. Immediate intravenous benzodiazepines (lorazepam 0.1 mg/kg or midazolam 0.1–0.2 mg/kg) are essential. Gastric lavage and ipecac are absolutely contraindicated because seizures occurring during gastric manipulation guarantee catastrophic pulmonary aspiration.
Methyl Salicylate (Oil of Wintergreen) : Pure methyl salicylate contains 98% methyl salicylate. One milliliter of oil of wintergreen is toxicologically equivalent to 1,400 mg of acetylsalicylic acid . A single teaspoon (5 mL) contains 7,000 mg of salicylate , equivalent to more than 21 adult 325 mg aspirin tablets or over 85 baby aspirin tablets (81 mg) . In a 10 kg toddler, one teaspoon represents an astronomical dose of 700 mg/kg (doses >300–500 mg/kg are potentially lethal). Children experience rapid uncoupling of oxidative phosphorylation, severe hyperpyrexia, profound mixed metabolic acidosis, neuroglycopenia, pulmonary edema, and sudden cardiovascular collapse. Emergent hemodialysis is indicated early.
Pediatric Toxic Dose Thresholds for Common Over-the-Counter Analgesics and Household Ingestions
Specialists in Poison Information must rapidly calculate weight-based doses to differentiate harmless exploratory sips from ingestions requiring emergency department dispatch. Core Pediatric Weight-Based Toxicity Thresholds:
- Acetaminophen: > 150–200 mg/kg → Requires 4-hour serum APAP level + Rumack-Matthew nomogram
- Ibuprofen: > 100 mg/kg → Symptomatic threshold; > 400 mg/kg = severe coma/acidosis
- Elemental Iron: > 20 mg/kg → Gastrointestinal toxicity; > 60 mg/kg = systemic shock
- Diphenhydramine: > 7.5 mg/kg → Severe anticholinergic delirium, seizures, QRS/QTc prolongation
- 1. Acetaminophen (APAP)
Acute Toxic Ingestion Threshold : > 150 to 200 mg/kg as a single acute ingestion (or >150 mg/kg/day over 24–48 hours in chronic supratherapeutic dosing).
Mechanism : Saturation of Phase II sulfation and glucuronidation shunts acetaminophen through CYP2E1, generating toxic N-acetyl-p-benzoquinone imine (NAPQI). Toddlers rely more heavily on sulfation than adults, which provides modest early protective reserve, but this pathway saturates rapidly in massive ingestion.
Triage : Any ingestion ≥ 150 mg/kg warrants emergency department referral for a 4-hour post-ingestion serum acetaminophen concentration plotted on the Rumack-Matthew nomogram, with initiation of N-acetylcysteine (NAC) if above the treatment line (150 mcg/mL at 4 hours).
2. Ibuprofen and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Toxicity Spectrum :
< 100 mg/kg : Non-toxic. Can be safely managed at home with oral fluids and parental observation.
100 to 400 mg/kg : Mild-to-moderate toxicity. Manifests with abdominal pain, nausea, vomiting, lethargy, and mild dizziness. Requires hospital evaluation.
> 400 mg/kg : Severe life-threatening toxicity. Causes high anion gap metabolic acidosis, profound central nervous system depression (coma, apnea), acute renal failure, hypokalemia, and generalized seizures.
3. Elemental Iron
Iron tablets differ widely in their percentage of elemental iron . Toxicity calculations must never use the total salt weight; they must always convert to elemental iron: Elemental Iron Content: Ferrous Sulfate ( 20 % ) ∣ Ferrous Gluconate ( 12 % ) ∣ Ferrous Fumarate ( 33 % ) ∣ Carbonyl Iron ( 100 % ) \text{Elemental Iron Content: } \text{Ferrous Sulfate } (20\%) \quad | \quad \text{Ferrous Gluconate } (12\%) \quad | \quad \text{Ferrous Fumarate } (33\%) \quad | \quad \text{Carbonyl Iron } (100\%) Elemental Iron Content: Ferrous Sulfate ( 20% ) ∣ Ferrous Gluconate ( 12% ) ∣ Ferrous Fumarate ( 33% ) ∣ Carbonyl Iron ( 100% ) Dose (mg/kg) = Number of Tablets × Tablet Salt Strength (mg) × % Elemental Iron Child Weight (kg) \text{Dose (mg/kg)} = \frac{\text{Number of Tablets} \times \text{Tablet Salt Strength (mg)} \times \text{\% Elemental Iron}}{\text{Child Weight (kg)}} Dose (mg/kg) = Child Weight (kg) Number of Tablets × Tablet Salt Strength (mg) × % Elemental Iron
Ingested Elemental Iron Dose Clinical Severity Stratification Anticipated Clinical Course & Management
< 20 mg/kg Non-toxic Asymptomatic or mild self-limited nausea; managed at home with parental observation.
20 to 60 mg/kg Mild to Moderate GI Toxicity Vomiting, hematemesis, abdominal pain, diarrhea; ED evaluation, abdominal radiograph, and baseline serum iron at 4 hours.
> 60 mg/kg Severe Systemic Toxicity Severe corrosive hemorrhagic gastritis, lactic acidosis, hypovolemic shock, hepatocellular necrosis; requires IV deferoxamine chelation .
> 100 mg/kg Potentially Lethal Multi-organ failure, refractory metabolic acidosis, bowel perforation, cardiovascular collapse; aggressive resuscitation, whole bowel irrigation, and emergent chelation.
4. Diphenhydramine (First-Generation Antihistamine)
Therapeutic Dose : 1.0 to 1.25 mg/kg every 6 hours (maximum 50 mg).
Referral Threshold : Ingestions of 7.5 mg/kg or more warrant emergency department referral and can produce anticholinergic toxicity: hyperthermia, dry flushed skin, muttering delirium, urinary retention, and mydriasis.
Cardiovascular and Neurological Hazards : At doses exceeding 10–15 mg/kg, diphenhydramine blocks cardiac fast inward sodium channels (producing QRS prolongation) and delayed rectifier potassium channels (QTc prolongation), predisposing the child to status epilepticus, torsades de pointes, and refractory wide-complex dysrhythmias.
Poison Center Case Scenario: The Toddler and Grandma's Pill Organizer
A frantic mother contacts the poison center at 10:30 AM. Her 2-year-old son (weight 12 kg) was found playing with his visiting grandmother's daily medication planner 15 minutes prior. The grandmother takes glipizide 10 mg daily for type 2 diabetes and amlodipine 10 mg daily for hypertension. The Monday morning compartment, which contained one tablet of each medication, is empty. The child is currently smiling, playing with toys, and completely asymptomatic.
Specialist in Poison Information Interventions
Risk Recognition : The CSPI recognizes that glipizide (10 mg = 0.83 mg/kg) and amlodipine (10 mg = 0.83 mg/kg) both represent classic "one-pill-can-kill" agents capable of inducing fatal delayed hypoglycemia and profound vasodilatory shock in a 12 kg toddler.
Immediate Triage : The CSPI instructs the mother to call 911 immediately for emergency department transport. The mother is specifically instructed not to induce vomiting and not to give excessive sugary juice, which would trigger early reactive insulin secretion.
Hospital Consultation Guidance : The CSPI contacts the receiving pediatric emergency department, warning the treating team that:
- Sulfonylurea hypoglycemia may be delayed past 12–16 hours;
- Boluses of IV dextrose alone will trigger rebound hyperinsulinemia;
- Bedside blood glucose must be monitored hourly;
Octreotide (1.25 mcg/kg = 15 mcg SC) must be available at the bedside to be administered immediately upon the first drop in blood glucose below 60–70 mg/dL;
Amlodipine will induce vasodilatory hypotension and secondary reflex tachycardia or nodal depression over the subsequent 6–12 hours, requiring continuous invasive arterial monitoring and preparation for high-dose insulin euglycemia therapy;
The child requires a mandatory minimum 24-hour intensive care observation period .